Global Cord Blood Corporation (CO) Stock Overview
Explore Global Cord Blood Corporation’s financial performance, market position, analyst ratings, and future outlook.
Global Cord Blood Corporation (CO)
Key Financials
Key Financials
Market Cap
400.1M
P/E Ratio
4.90
EPS (TTM)
$0.59
ROE
0.11%
CO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Global Cord Blood Corporation (CO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.78.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.90 and a market capitalization of 400.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.